Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 3-(2-furoylamino)benzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

300827-75-2

Post Buying Request

300827-75-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

300827-75-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 300827-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,0,8,2 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 300827-75:
(8*3)+(7*0)+(6*0)+(5*8)+(4*2)+(3*7)+(2*7)+(1*5)=112
112 % 10 = 2
So 300827-75-2 is a valid CAS Registry Number.

300827-75-2Downstream Products

300827-75-2Relevant academic research and scientific papers

Synthesis and biological evaluation of 2,5-diaryl-1,3,4-oxadiazole derivatives as novel Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) inhibitors

Meng, Xiang-Dong,Gao, Li-Xin,Wang, Zhi-Jia,Feng, Bo,Zhang, Chun,Satheeshkumar, Rajendran,Li, Jia,Zhu, Yun-Long,Zhou, Yu-Bo,Wang, Wen-Long

, (2021/10/04)

The Src homology-2 domain containing-protein tyrosine phosphatase-2 (SHP2) is a convergent node for oncogenic cell-signaling cascades including the PD-L1/PD-1 pathway. As an oncoprotein as well as a potential immunomodulator, SHP2 has now emerged as an attractive target for novel anti-cancer agents. Although significant progress has been made in identifying chemotypes of SHP2 inhibitors, these specific compounds might not be clinically useful to inhibit frequently encountered mutated SHP2 variants. Consequently, it is highly desirable to develop chemically different SHP2 inhibitors sensitive to SHP2 mutants. This work developed a new type of SHP2 inhibitors with 2,5-diaryl-1,3,4-oxadiazole scaffold. The representative compound 6l exhibited SHP2 inhibitory activity with IC50 of 2.73 ± 0.20 μM, showed about 1.56-fold, 5.26-fold, and 7.36-fold selectivity for SHP2 over SHP1, PTP1B and TCPTP respectively. Further investigations confirmed that 6l behaved as mixed-type inhibitor sensitive to leukemia cell TF-1 and inhibited SHP2 mediated cell signaling and proliferation. Molecular dynamics simulation provided more detailed information on the binding modes of compounds and SHP2 protein. These preliminary results could provide a possible opportunity for the development of novel SHP2 inhibitors sensitive to SHP2 mutants with optimal potency and improved pharmacological properties.

Pd-catalyzed cross-coupling reactions of amides and aryl mesylates

Dooleweerdt, Karin,Fors, Brett P.,Buchwald, Stephen L.

supporting information; experimental part, p. 2350 - 2353 (2010/07/06)

A catalyst, based on a biarylphosphine ligand, for the Pd-catalyzed cross-coupling reactions of amides and aryl mesylates is described. This system allows an array of aryl and heteroaryl mesylates to be transformed into the corresponding N-aryl amides in moderate to excellent yields.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 300827-75-2